ZBH Zimmer Biomet Holdings, Inc.
Healthcare
Price
$97.87
Intrinsic value
$37.00
Buy price
$29.60
Discount
-164.5%
DCF walkthrough
Near-term growth (g1)5.85%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $1,743,300,000.00
- Total debt
- $7,601,699,840.00
- Cash & STI
- $464,500,000.00
- Shares out.
- 192,800,000
Overvalued
Intrinsic value$36.98
Buy price (with MOS)$29.59
Current price$97.87
Discount to intrinsic value-164.6%
7-step quality scorecard
ROE quality
LOW- Average ROE
- 5.7%
- Current ROE
- 5.6%
- Minimum ROE
- 1.9%
Debt quality
MODERATE- Debt / Equity
- 0.60x
Moat proxy
MODERATE_PROXYCash-flow reliability
OK- Operating CF / Net income
- 2.16x
Technical chart
Confluence: WEAK (1/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- min(revenueCAGR,cfCAGR)
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 53.2%
- Public economic interest
- 99.9%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.